Yang Xiang to Epstein-Barr Virus Infections
This is a "connection" page, showing publications Yang Xiang has written about Epstein-Barr Virus Infections.
Connection Strength
0.397
-
Jiang C, Li L, Xiang YQ, Lung ML, Zeng T, Lu J, Tsao SW, Zeng MS, Yun JP, Kwong DLW, Guan XY. Epstein-Barr Virus miRNA BART2-5p Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing RND3. Cancer Res. 2020 05 15; 80(10):1957-1969.
Score: 0.143
-
Li WZ, Liu GY, Lin LF, Lv SH, Qiang MY, Lv X, Wu YS, Liang H, Ke LR, Wang DL, Yu YH, Qiu WZ, Liu KY, Guo X, Li JP, Zou YJ, Xiang YQ, Xia WX. MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of it. Radiother Oncol. 2020 04; 145:101-108.
Score: 0.143
-
Guo SS, Tang LQ, Chen QY, Zhang L, Liu LT, Guo L, Mo HY, Luo DH, Huang PY, Xiang YQ, Sun R, Chen MY, Wang L, Lv X, Zhao C, Guo X, Cao KJ, Qian CN, Zeng MS, Bei JX, Hong MH, Shao JY, Sun Y, Ma J, Mai HQ. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA =4000 copies/ml: a matched study. Oncotarget. 2016 May 17; 7(20):29739-48.
Score: 0.111